Mapping the Future for Clinical Outcomes at OUI
Dr Liisa Chisty joins Oxford University Innovation's Clinical Outcomes Team, reinforcing their commitment to patient-centric care and licensing Clinical Outcome Assessments (COAs).
Beacon Therapeutics spun out by Syncona and Oxford raises £96 million for retinal gene therapy
Beacon Therapeutics, a pioneering new biotech company, has launched with a mission to restore and improve the vision of patients with retinal diseases. The company is one of the most ambitious spinouts the University has been involved in to date, starting out with an impressive £96 million ($118.5m) in funding, the biggest launch for any company including an Oxford spin-out programme.
Oxford Alumna and Cancer Survivor Launches New App to Support Cancer Patients
- MBA Graduate Ani Hakyuni’s own experience surviving cancer inspires new startup.
- The app, Vann, will create support groups for people battling cancer.
- Vann will provide key insights to support clinician decision making in oncology.
OUI Incubator welcomes cohort six to Phase 2
Take a glimpse into the future with startups emerging from OUI’s incubator.
Oxford University showcases world-class labs and facilities
OUI, Bioescalator and the Oxford Trust team up to showcase the University's facilities to the Oxford ecosystem.
Oxford University retains No. 1 spot for spinouts
The 2023 Spotlight on Spinouts report once again underlines Oxford’s leading position in spinout creation. The report underlines Oxford Science Enterprises’ positive impact on Oxford’s spinout community, while investments into Oxford spinouts remain high, despite UK-wide downturn.
Crafting the Jamie’s: where chemistry and art meet
Meet Terri Adams, the local glassblower designing the trophies for the upcoming Jamie Ferguson Chemistry Awards.
Top universities boost investor confidence with new spinout framework to spur economic growth
The University of Oxford partners with top universities and investors to agree terms which will greatly increase the UK’s capacity to turn world-leading research into spinouts that will generate economic growth and societal impact.
Latest data shows University equity share has a limited effect on multiple spinout fundraising factors
A statistical analysis of 650 UK spinouts between 2010 and 2021 shows that the university proportion of equity share has a limited effect on multiple fundraising factors including the probability of spinouts raising equity, the amount of funding raised, and the market valuation of a spinout after it has received funding.
© Oxford University Innovation